loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Otsuka Chemical Co Ltd's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ARIPIPRAZOLE (20)

02 BREXPIPRAZOLE (6)

03 CEDAZURIDINE; DECITABINE (1)

04 CILOSTAZOL (2)

05 DECITABINE (1)

06 FERRIC AMMONIUM CITRATE (1)

07 GREPAFLOXACIN HYDROCHLORIDE (3)

08 TOLVAPTAN (8)

filter

01 OTSUKA (42)

filter

01 FOR SOLUTION;ORAL (1)

02 INJECTABLE;INTRAMUSCULAR (1)

03 INJECTABLE;INTRAVENOUS (1)

04 SOLUTION;ORAL (1)

05 SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR (2)

06 TABLET, ORALLY DISINTEGRATING;ORAL (4)

07 TABLET;ORAL (32)

filter

01 0.25MG (1)

02 0.5MG (1)

03 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

04 100MG;35MG (1)

05 10MG (2)

06 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

07 15MG (4)

08 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

09 1MG (1)

10 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

11 20MG (2)

12 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

13 2MG (3)

14 30MG (4)

15 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

16 3MG (1)

17 45MG (1)

18 4MG (1)

19 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

20 50MG/VIAL (1)

21 5MG (2)

22 600MG/PACKET (1)

23 60MG (1)

24 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

25 720MG/2.4ML (300MG/ML) (1)

26 9.75MG/1.3ML (7.5MG/ML) (1)

27 90MG (1)

28 960MG/3.2ML (300MG/ML) (1)

29 EQ 200MG BASE (1)

30 EQ 400MG BASE (1)

31 EQ 600MG BASE (1)

filter

01 USA (42)

URL Supplier Web Content
TABLET;ORAL
15MG
ABILIFY
USA
21436
2002-11-15
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
5MG
ABILIFY
USA
21436
2002-11-15
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;ORAL
1MG/ML **Federal Regis...
ABILIFY
USA
21713
2004-12-10
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DISINTE...
20MG **Federal Registe...
ABILIFY
USA
21729
2006-06-07
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, ORALLY DISINTE...
30MG **Federal Registe...
ABILIFY
USA
21729
2006-06-07
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INTRAMUSCUL...
9.75MG/1.3ML (7.5MG/ML...
ABILIFY
USA
21866
2006-09-20
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
2MG
ABILIFY MYCITE KIT
USA
207202
2017-11-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
15MG
ABILIFY MYCITE KIT
USA
207202
2017-11-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
30MG
ABILIFY MYCITE KIT
USA
207202
2017-11-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION, EXTENDED R...
960MG/3.2ML (300MG/ML)
ABILIFY ASIMTUFII
USA
217006
2023-04-27
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY